- Home
- Publications
- Publication Search
- Publication Details
Title
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Authors
Keywords
-
Journal
OncoImmunology
Volume 11, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2022-07-05
DOI
10.1080/2162402x.2022.2096363
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
- (2022) Emma Verheye et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunogenic cell stress and death
- (2022) Guido Kroemer et al. NATURE IMMUNOLOGY
- Harnessing cytokines and chemokines for cancer therapy
- (2022) David J. Propper et al. Nature Reviews Clinical Oncology
- A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology
- (2022) Jenny Sprooten et al. OncoImmunology
- Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1/PD-L1 blockade immunotherapeutic response in cervical cancer
- (2022) Yu-meng Wang et al. OncoImmunology
- Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy
- (2022) Hyein Jeong et al. OncoImmunology
- Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2022) Nicholas J. Vogelzang et al. JAMA Oncology
- An autologous dendritic cell vaccine promotes anticancer immunity in ovarian cancer patients with low mutational burden and cold tumors
- (2022) Jitka Fucikova et al. CLINICAL CANCER RESEARCH
- Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
- (2022) Giulia Petroni et al. NATURE REVIEWS DRUG DISCOVERY
- Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression
- (2022) Donghwan Jeon et al. OncoImmunology
- Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy
- (2022) Adriana Petrazzuolo et al. OncoImmunology
- The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity
- (2022) Yasuyuki Saito et al. Cancers
- Human dendritic cells in cancer
- (2022) Egle Kvedaraite et al. Science Immunology
- Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases
- (2021) Rajesh Ramanathan et al. ANNALS OF SURGICAL ONCOLOGY
- Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12
- (2021) Qingxiang Li et al. OncoImmunology
- A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
- (2021) Timothy J. Vreeland et al. ANNALS OF SURGICAL ONCOLOGY
- Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model
- (2021) Dina Stroopinsky et al. HAEMATOLOGICA
- Dendritic cells: The first step
- (2021) Gwendalyn J. Randolph JOURNAL OF EXPERIMENTAL MEDICINE
- Intratumoral heterogeneity in cancer progression and response to immunotherapy
- (2021) Ilio Vitale et al. NATURE MEDICINE
- PD-L1 as a biomarker of response to immune-checkpoint inhibitors
- (2021) Deborah Blythe Doroshow et al. Nature Reviews Clinical Oncology
- Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
- (2021) Karthik Dhatchinamoorthy et al. Frontiers in Immunology
- The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake
- (2021) Álvaro de Mingo Pulido et al. IMMUNITY
- Revisiting Current Concepts on the Tolerogenicity of Steady-State Dendritic Cell Subsets and Their Maturation Stages
- (2021) Manfred B. Lutz et al. JOURNAL OF IMMUNOLOGY
- Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
- (2021) Sarah I. M. Sutherland et al. Frontiers in Immunology
- A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine
- (2021) Wei Shi et al. CANCER LETTERS
- Mechanisms of Therapeutic Antitumor Monoclonal Antibodies
- (2021) Li-Chung Tsao et al. CANCER RESEARCH
- Antigen Loss after Targeted Immunotherapy in Hematological Malignancies
- (2021) Ting Zhou et al. CLINICS IN LABORATORY MEDICINE
- Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy
- (2021) Isaure Vanmeerbeek et al. GENES AND IMMUNITY
- Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial
- (2021) David Cibula et al. GYNECOLOGIC ONCOLOGY
- PD-L1 expression as a predictive biomarker for immune checkpoint inhibitors: between a dream and a nightmare
- (2021) Joseph Zouein et al. Immunotherapy
- Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
- (2021) Ivan Y. Filin et al. Frontiers in Oncology
- Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit
- (2021) Emily Nickles et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Conventional type 1 dendritic cells (cDC1) as cancer therapeutics: challenges and opportunities
- (2021) Phillip Johnson et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction
- (2021) Karina J. Lagos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Strategy and clinical application of up-regulating cross presentation by DCs in anti-tumor therapy
- (2021) Yichao Lu et al. JOURNAL OF CONTROLLED RELEASE
- Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy
- (2021) Anne M. A. Tryggestad et al. PROSTATE
- Targeting CD166+ lung cancer stem cells: Molecular study using murine dendritic cell vaccine
- (2021) N.E. El-Ashmawy et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer
- (2021) Ward Celus et al. Cancer Immunology Research
- Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients
- (2021) Martine Bloemendal et al. OncoImmunology
- Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer
- (2021) Jenny Sprooten et al. Journal for ImmunoTherapy of Cancer
- Immunological configuration of ovarian carcinoma: features and impact on disease outcome
- (2021) Jitka Fucikova et al. Journal for ImmunoTherapy of Cancer
- Radical or Not-So-Radical Prostatectomy: Do Surgical Margins Matter?
- (2021) Ioanna Maria Grypari et al. Cancers
- Safety and efficacy of dendritic cell-based immunotherapy (DCVAC/LuCa) combined with carboplatin/pemetrexed for patients with advanced non-squamous non-small-cell lung cancer without oncogenic drivers
- (2021) R. Zhong et al. ESMO Open
- Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients
- (2020) Qian-Ting Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
- (2020) Steve Boudewijns et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma
- (2020) Robert A. Figlin et al. CLINICAL CANCER RESEARCH
- DC-CIK as a widely applicable cancer immunotherapy
- (2020) Shuo Wang et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
- (2020) Isaure Vanmeerbeek et al. OncoImmunology
- Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer
- (2020) Johnie Hodge et al. OncoImmunology
- Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity
- (2020) Shumei Kato et al. OncoImmunology
- Deep neural network classification based on somatic mutations potentially predicts clinical benefit of immune checkpoint blockade in lung adenocarcinoma
- (2020) Jie Peng et al. OncoImmunology
- TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
- (2020) Brenda De Keersmaecker et al. Journal for ImmunoTherapy of Cancer
- Cross-Presenting XCR1+ Dendritic Cells as Targets for Cancer Immunotherapy
- (2020) Katherine M. Audsley et al. Cells
- Ex vivo pulsed dendritic cell vaccination against cancer
- (2020) Yang-zhuo Gu et al. ACTA PHARMACOLOGICA SINICA
- Acquired Resistance to Immune Checkpoint Inhibitors
- (2020) Adam J. Schoenfeld et al. CANCER CELL
- Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model
- (2020) Yanling Liu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma
- (2020) Jeremy D. Rudnick et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Dendritic Cells and Their Role in Immunotherapy
- (2020) Alycia Gardner et al. Frontiers in Immunology
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
- (2020) David A. Reardon et al. JAMA Oncology
- Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+conventional dendritic cells
- (2020) Yifan Zhou et al. Journal for ImmunoTherapy of Cancer
- Engineering CAR-T Cells for Next-Generation Cancer Therapy
- (2020) Mihe Hong et al. CANCER CELL
- A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
- (2020) Yanina Jansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors
- (2020) Robin Fröbom et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic Cells Currently under the Spotlight; Classification and Subset Based upon New Markers
- (2020) Samaneh Soltani et al. IMMUNOLOGICAL INVESTIGATIONS
- Dendritic cell therapy in cancer treatment; the state-of-the-art
- (2020) Mahsa Sadeghzadeh et al. LIFE SCIENCES
- Antitumour dendritic cell vaccination in a priming and boosting approach
- (2020) Alexandre Harari et al. NATURE REVIEWS DRUG DISCOVERY
- Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions
- (2020) Massimo Ralli et al. Journal of Immunology Research
- Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
- (2020) Sai Ping Lau et al. Journal for ImmunoTherapy of Cancer
- Necroptosis in Immuno-Oncology and Cancer Immunotherapy
- (2020) Jenny Sprooten et al. Cells
- IL-12 from endogenous cDC1, and not vaccine DC, is required for Th1 induction
- (2020) DiyaaElDin Ashour et al. JCI Insight
- Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial
- (2020) KAZUHIRO NAGAI et al. ANTICANCER RESEARCH
- Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial
- (2020) Hiroto Matsui Matsui et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic cell biology and its role in tumor immunotherapy
- (2020) Yingying Wang et al. Journal of Hematology & Oncology
- Novel concepts in plasmacytoid dendritic cell (pDC) development and differentiation
- (2020) Patrick Fernandes Rodrigues et al. MOLECULAR IMMUNOLOGY
- Tackling Resistance to Cancer Immunotherapy: What Do We Know?
- (2020) Soehartati A. Gondhowiardjo et al. MOLECULES
- Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients
- (2020) Matthew S. Block et al. Nature Communications
- Immunomodulation by targeted anticancer agents
- (2020) Giulia Petroni et al. CANCER CELL
- Tumor-infiltrating dendritic cell states are conserved across solid human cancers
- (2020) Genevieve M. Gerhard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma
- (2020) Roxanne Wouters et al. Cancers
- N-terminal VP1 Truncations Favor T = 1 Norovirus-Like Particles
- (2020) Ronja Pogan et al. Vaccines
- A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine
- (2019) Hyun Jin Park et al. Journal for ImmunoTherapy of Cancer
- Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
- (2019) Mikhail Binnewies et al. CELL
- Chimeric antigen receptor T cell therapy and other therapeutics for malignancies: Combination and opportunity
- (2019) Luyao Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Phase I/II pilot study of WT1 peptide‐pulsed dendritic cell vaccination combined with conventional chemotherapy in patients with head and neck cancer
- (2019) Masahiro Ogasawara et al. THERAPEUTIC APHERESIS AND DIALYSIS
- The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
- (2019) Kalijn F. Bol et al. Journal for ImmunoTherapy of Cancer
- Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma
- (2019) Lisa H. Butterfield et al. Journal for ImmunoTherapy of Cancer
- Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab
- (2019) M. Christina Cox et al. CLINICAL CANCER RESEARCH
- A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma
- (2019) Patrick Y. Wen et al. CLINICAL CANCER RESEARCH
- Targeting mTOR for cancer therapy
- (2019) Hui Hua et al. Journal of Hematology & Oncology
- Plasmacytoid dendritic cells develop from Ly6D+ lymphoid progenitors distinct from the myeloid lineage
- (2019) Regine J. Dress et al. NATURE IMMUNOLOGY
- Mechanisms of immunotherapy resistance: lessons from glioblastoma
- (2019) Christopher M. Jackson et al. NATURE IMMUNOLOGY
- Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
- (2019) Reem Saleh et al. SEMINARS IN CANCER BIOLOGY
- PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
- (2019) Ali S. Alzahrani SEMINARS IN CANCER BIOLOGY
- An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine
- (2019) Jitao Guo et al. Cancer Immunology Research
- Trial watch: dendritic cell vaccination for cancer immunotherapy
- (2019) Jenny Sprooten et al. OncoImmunology
- Killers 2.0: NK cell therapies at the forefront of cancer control
- (2019) Jonathan J. Hodgins et al. JOURNAL OF CLINICAL INVESTIGATION
- A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients
- (2019) Michal Bassani-Sternberg et al. Frontiers in Immunology
- Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine
- (2019) Caterina Lapenta et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity
- (2019) Chrysothemis C. Brown et al. CELL
- Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence
- (2019) Samuel J. Klempner et al. ONCOLOGIST
- The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
- (2019) Rikito Endo et al. Scientific Reports
- The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
- (2019) Peter G. Hendrickson et al. OncoImmunology
- A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer
- (2019) Christa I. DeVette et al. OncoImmunology
- Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
- (2019) Harm Westdorp et al. Journal for ImmunoTherapy of Cancer
- Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling
- (2019) Farhad Dastmalchi et al. Journal for ImmunoTherapy of Cancer
- Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
- (2019) Rui Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
- (2018) Daniel Rojas-Sepúlveda et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions
- (2018) Catherine E Handy et al. Future Oncology
- Human dendritic cell subsets: an update
- (2018) Matthew Collin et al. IMMUNOLOGY
- Dendritic Cell–Based Cancer Vaccines
- (2018) Patricia M. Santos et al. JOURNAL OF IMMUNOLOGY
- Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma
- (2018) Larisa J. Geskin et al. MELANOMA RESEARCH
- Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells
- (2018) Patrick Fernandes Rodrigues et al. NATURE IMMUNOLOGY
- Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration
- (2018) Alex Karlsson-Parra et al. PHARMACEUTICAL RESEARCH
- Dendritic Cell-Based Immunotherapy for Solid Tumors
- (2018) Nam-Chul Jung et al. Translational Oncology
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Cytokines in clinical cancer immunotherapy
- (2018) Pedro Berraondo et al. BRITISH JOURNAL OF CANCER
- Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
- (2018) Alberto A. Chiappori et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma
- (2018) Shan Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Linking cellular stress responses to systemic homeostasis
- (2018) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Current State of Dendritic Cell-Based Immunotherapy: Opportunities for in vitro Antigen Loading of Different DC Subsets?
- (2018) Anne Huber et al. Frontiers in Immunology
- Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
- (2018) Chunmei Fu et al. Frontiers in Immunology
- Next-generation dendritic cell-based vaccines for leukemia patients
- (2017) Jean-Marc Hoffmann et al. Immunotherapy
- Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
- (2017) Abhishek D. Garg et al. TRENDS IN IMMUNOLOGY
- Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
- (2017) Grammatiki Fotaki et al. OncoImmunology
- Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial
- (2017) David J. Chung et al. OncoImmunology
- Trial watch: Dendritic cell-based anticancer immunotherapy
- (2017) Abhishek D. Garg et al. OncoImmunology
- Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
- (2016) A D Garg et al. CELL DEATH AND DIFFERENTIATION
- Advances and challenges: dendritic cell vaccination strategies for glioblastoma
- (2016) Teilo H. Schaller et al. Expert Review of Vaccines
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- In situvaccination for the treatment of cancer
- (2016) Linda Hammerich et al. Immunotherapy
- Comparative genomics analysis of mononuclear phagocyte subsets confirms homology between lymphoid tissue-resident and dermal XCR1+ DCs in mouse and human and distinguishes them from Langerhans cells
- (2016) Sabrina Carpentier et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
- (2016) J. Rosenblatt et al. Science Translational Medicine
- Antitumor dendritic cell–based vaccines: lessons from 20 years of clinical trials and future perspectives
- (2016) João Constantino et al. Translational Research
- The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
- (2016) Damya Laoui et al. Nature Communications
- Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death
- (2016) Stefania Di Blasio et al. OncoImmunology
- Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
- (2015) G. Schreibelt et al. CLINICAL CANCER RESEARCH
- Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
- (2015) Helen M. Lazear et al. IMMUNITY
- Microbial DNA Recognition by cGAS-STING and Other Sensors in Dendritic Cells in Inflammatory Bowel Diseases
- (2015) Song Liu et al. INFLAMMATORY BOWEL DISEASES
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow
- (2015) Andreas Schlitzer et al. NATURE IMMUNOLOGY
- Tumor cell lysates as immunogenic sources for cancer vaccine design
- (2015) Fermín E González et al. Human Vaccines & Immunotherapeutics
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Dendritic cell vaccine against leukemia: advances and perspectives
- (2014) Dige Andom Tesfatsion Immunotherapy
- HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells
- (2014) Stéphanie Demoulin et al. INTERNATIONAL JOURNAL OF CANCER
- Human XCR1+Dendritic Cells Derived In Vitro from CD34+Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells
- (2014) Sreekumar Balan et al. JOURNAL OF IMMUNOLOGY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
- (2013) Abhishek D. Garg et al. BIOFACTORS
- Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses
- (2013) G. Nizzoli et al. BLOOD
- Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients
- (2013) J. Tel et al. CANCER RESEARCH
- Human dendritic cell subsets
- (2013) Matthew Collin et al. IMMUNOLOGY
- Controlling immune responses by targeting antigens to dendritic cell subsets and B cells
- (2013) Craig P. Chappell et al. INTERNATIONAL IMMUNOLOGY
- Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells
- (2013) Vanja Sisirak et al. INTERNATIONAL JOURNAL OF CANCER
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Plasmacytoid Dendritic Cells Support Melanoma Progression by Promoting Th2 and Regulatory Immunity through OX40L and ICOSL
- (2013) C. Aspord et al. Cancer Immunology Research
- Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN
- (2012) Luis J. Cruz et al. BIOMATERIALS
- CXCL10 Is Critical for the Generation of Protective CD8 T Cell Response Induced by Antigen Pulsed CpG-ODN Activated Dendritic Cells
- (2012) Saikat Majumder et al. PLoS One
- Activation of dendritic cells by tumor cell death
- (2012) Mara Cirone et al. OncoImmunology
- Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer
- (2011) S. I. Labidi-Galy et al. CANCER RESEARCH
- Ralph M. Steinman 1943–2011
- (2011) Antonio Lanzavecchia et al. CELL
- Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients
- (2011) Hisahito Endo et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Dendritic Cells and Damage-Associated Molecular Patterns: Endogenous Danger Signals Linking Innate and Adaptive Immunity
- (2011) Gary Nace et al. Journal of Innate Immunity
- Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials
- (2011) Jitka Fučíková et al. Journal of Translational Medicine
- Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?
- (2010) S. Viaud et al. CANCER RESEARCH
- Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets
- (2010) Karine Crozat et al. IMMUNOLOGICAL REVIEWS
- Mouse CD8α+DCs and human BDCA3+DCs are major producers of IFN-λ in response to poly IC
- (2010) Henning Lauterbach et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis and Characterization of Antitumor T-cell Response After Administration of Dendritic Cells Loaded With Allogeneic Tumor Lysate to Metastatic Melanoma Patients
- (2009) Nadege Bercovici et al. JOURNAL OF IMMUNOTHERAPY
- Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells
- (2008) Rebecca J. Dearman et al. IMMUNOLOGY
- TLR ligand–induced podosome disassembly in dendritic cells is ADAM17 dependent
- (2008) Michele A. West et al. JOURNAL OF CELL BIOLOGY
- Whole tumor antigen vaccination using dendritic cells: Comparison of RNA electroporation and pulsing with UV-irradiated tumor cells
- (2008) Fabian Benencia et al. Journal of Translational Medicine
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More